MARA Reports Higher Month-Over-Month Bitcoin Production in September-March 2024-www.financetom.com

MARA Reports Higher Month-Over-Month Bitcoin Production in September

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

MARA Reports Higher Month-Over-Month Bitcoin Production in September

Oct 2, 2024 10:57 PM

08:41 AM EDT, 10/02/2024 (MT Newswires) -- MARA Holdings ( MARA ) said Wednesday it produced 705 bitcoins in September, up 5% from August.

No year-ago comparisons were reported.

The firm had 26,842 bitcoins at the end of September, it added.

MARA also said it increased its month-over-month energized hash rate by 5% in September to 36.9 exahash.

Price: 14.87, Change: -0.20, Percent Change: -1.33

Previous page： Cassava Sciences Q3 net loss narrows, beats expectations Next page： Microdisplays maker Kopin Q3 revenue misses expectations

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cassava Sciences Q3 net loss narrows, beats expectations

Nov 12, 2025

Overview * Cassava Sciences ( SAVA ) Q3 net loss narrows to $10.8 mln, beating analyst expectations * Company advancing simufilam for TSC-related epilepsy, study planned for H1 2026 * Cash and cash equivalents at $106.1 mln, expected to support operations into 2027 Outlook * Cassava plans proof-of-concept study for simufilam in TSC-related epilepsy in H1 2026 * Company revises...

Microdisplays maker Kopin Q3 revenue misses expectations

Nov 12, 2025

Overview * Kopin ( KOPN ) Q3 revenue misses analyst expectations, adjusted EPS beats estimates * Net income for Q3 exceeds analyst estimates, reflecting improved financial performance * Company forms strategic partnerships to expand international market access Outlook * Kopin ( KOPN ) expects to grow aggressively in U.S. and international markets * Company notes increased defense budgets in U.S.,...

Artelo Biosciences Q3 net loss widens to $3.1 mln

Nov 12, 2025

Overview * Artelo Biosciences ( ARTL ) reports Q3 net loss of $3.1 mln, increased R&D and G&A expenses * Positive interim Phase 2 data for ART27.13 attracts partnering interest * Company completed public offering of common stock for $3.0 mln Outlook * Company expects first-in-human study for ART12.11 to start in 1H 2026 * Artelo sees partnering interest for...

Allurion Technologies Q3 revenue beats expectations

Nov 12, 2025

Overview * Allurion ( ALUR/WS ) Q3 revenue of $2.7 mln beats analyst expectations despite a year-over-year decline * Company reduced operating expenses by 29% and operating loss by 22% year-over-year * Allurion ( ALUR/WS ) exchanged debt for convertible preferred equity and secured $5 mln private placement Outlook * Company did not provide specific financial guidance for future quarters...